: Drug Design & Medicinal Chemistry

Drug Design & Medicinal Chemistry

June 2023 | Berlin, Germany
9th Annual
Drug Design & Medicinal Chemistry Congress
26 - 27 October 2021 | London, UK
+ Digital Day: 28 October 2021 | Online

Bringing you the latest in enabling technologies, computational-based drug design and discovery chemistry. Key focus areas include: DNA-encoded libraries, protein-to-protein interactions, AI/ML in drug design, and medicinal chemistry for oncology

Drug Design and Medicinal Chemistry Congress includes...​

Join over 400 leaders, experts and scientists at this event, helping to shape the future of discovery chemistry and computational drug design:

Learn about key focus areas include DNA encoded libraries, protein-protein interactions, AI/ML in drug design and new modalities such as Protein Degradation and Covalent Inhibitors.

Gain successful strategies in compound library development, DNA/RNA encoded libraries, protein to protein interaction, fragment and structured based drug design

Focusing on cutting edge tools, including: AI in ADME, big data management, model management, artificial intelligence, machine learning in drug design and AI in chemical synthesis, AI-enabled target ID capabilities, lead identification/optimisation

Engage in interactive discussions on the Integration Of DEL, Covalent Inhibitors and Protein Degradation Technologies In The Optimization Of HITs.

Supported digitally on our fully featured online event platform, with selected presentations available to watch on-demand and extensive networking features.

Agenda at a Glance

Day One

Morning Sessions:

Stream 4: Computational Drug Design: AI Focus

Afternoon Interactive Roundtable Sessions:

Roundtable Discussions:

  • Addressing Difficult Targets with New Novel Approaches in Drug Design
  • AI in Drug Design – Where Are We?
  • Digitising Drug Discovery Labs
  • AI & Data Analysis


Workshop: 
Deploying 3D Modelling To Chemists

Day Two

Stream 3: Integration Of Technologies In The Optimization Of HITs – DEL, Covalent Inhibitors and Protein Degradation

Stream 4: Molecular Drug Design and Medicinal Chemistry

Interactive Roundtable Discussions:

  • New Chemical Modalities and Challenging Targets: (Small and Large Molecules) and Choice of Modalities
  • Covalent Inhibitors Design and Discovery – Overcoming Challenges

Key Speakers

The 2021 event again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.

Malcolm Weir

Malcolm Weir

Executive Officer, Vice President
Sosei Heptares
Ulrich Betz

Ulrich Betz

Vice President Innovation, Head of Department Innovation Incubator
Merck
Matthias Frech

Matthias Frech

Director, Molecular Interactions & Biophysics
Merck
Clara Christ

Clara Christ

Head of Computational Molecular Design
Bayer
Olivier Nosjean

Olivier Nosjean

Head of Open Innovation and Scientific Affairs, R&D
Servier
Nadeem Sarwar

Nadeem Sarwar

Global Head, Genomic Strategies & Global Head, Digital Therapeutics (DTx) Strategies
Eisai

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.